Publications by authors named "Mike Horton"

Objectives: Using Rasch measurement theory, an item pool of 12 questions has been identified, covering tenderness and swelling, disease activity, pain, physical functioning and stiffness for assessing the construct of RA disease activity. This study aimed to assess the content validity of this item pool using cognitive interviews.

Methods: Participants were randomly sampled across varying age, sex and education level categories from respondents to a survey containing RA disease activity Patient Reported Outcome Measures.

View Article and Find Full Text PDF

Objectives: Little is understood about the lived experiences of individuals affected by inherited optic neuropathies (IONs) in the United Kingdom. The aim of this study was to understand how autosomal dominant optic atrophy (DOA) and Leber hereditary optic neuropathy, the 2 more commonly encountered IONs, impact affected individuals and the factors contributing to their vision-related quality of life (VRQoL).

Methods: Semistructured qualitative interviews were conducted with 20 individuals with a genetic diagnosis of DOA (10 participants) or Leber hereditary optic neuropathy (10 participants) and affected by vision loss.

View Article and Find Full Text PDF

Background: Increasingly, patient-reported outcome measures (PROMs) are used to monitor chronic kidney disease (CKD) symptoms in routine clinical practice. However, such symptom measurement currently requires completion of multiple, often lengthy, PROMs, which may lead to questionnaire fatigue, lower levels of completion, and missing data. Moreover, many CKD-specific PROMs lack evidence of important measurement properties and few were developed using contemporary psychometric methods.

View Article and Find Full Text PDF

Objectives: Disease activity (DA) monitoring is a standard of care in RA. There is demand for achieving this through patient-reported outcome measures (PROMs). The aim of this study was to determine which items could be used to measure the construct of RA DA, by analysing legacy PROMs, using Rasch measurement theory (RMT) analyses.

View Article and Find Full Text PDF

Background: Long COVID (LC) is a clinical syndrome with persistent, fluctuating symptoms subsequent to COVID-19 infection. LC has significant detrimental effects on health-related quality of life (HRQoL), activities of daily living (ADL), and work productivity. Condition-specific patient-reported outcome measures (PROMs), such as the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) do not provide the health utility data required for cost-utility analyses of LC interventions.

View Article and Find Full Text PDF
Article Synopsis
  • - The R-PAct scale is designed to measure how Pompe disease affects daily life, and this study aimed to validate it for use in different languages and countries.
  • - Researchers created German, French, Italian, and Spanish versions of the scale and collected data from Pompe patients in several countries, combining it with existing data for analysis.
  • - Results showed that the modified R-PAct scale is valid and effectively measures two key areas of patient activity, with a minor adjustment made to improve its reliability across diverse populations.
View Article and Find Full Text PDF

Study Objectives: To translate, culturally adapt, and validate the Neurological Sleep Index-Multiple Sclerosis (NSI-MS) for use in Austrian German-speaking populations with multiple sclerosis.

Methods: Following established guidelines, the NSI-MS diurnal sleepiness, nonrestorative nocturnal sleep, and fragmented nocturnal sleep scales underwent forward-backward translation, with content and face validity, and cultural adaptation to Austria established. Construct validity was evaluated using Rasch analysis.

View Article and Find Full Text PDF

Background: Left ventricular assist device (LVAD) recipients report symptom improvement but find adjusting to life with the LVAD challenging. These challenges are unique, and existing patient-reported outcome measures (PROMs) do not reflect their experiences. This study aimed to develop a culturally relevant quality of life PROM for use with LVAD recipients in future research, design evolutions and clinical practice.

View Article and Find Full Text PDF

Background: Long COVID (LC) is a novel multisystem clinical syndrome affecting millions of individuals worldwide. The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) is a condition-specific patient-reported outcome measure designed for assessment and monitoring of people with LC.

Objectives: To evaluate the psychometric properties of the C19-YRSm in a prospective sample of people with LC.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to determine the psychometric validity of the Visual Function Index (VF-14) for use by patients with Leber hereditary optic neuropathy (LHON).

Methods: Rasch analysis was conducted in two stages using data for 196 individuals (74.5% male) carrying one of the three primary LHON mutations and affected by vision loss.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to develop and validate the Neurological Fatigue Index - Multiple Sclerosis (NFI-MS), a patient-reported outcome measure that captures the fatigue experienced by individuals with multiple sclerosis, using the Rasch model framework.
  • A sample of 309 MS patients participated in the validation process, completing the German version of the NFI-MS (NFI-MS-G) alongside other questionnaires to assess its reliability and validity over a short time period following rehabilitation.
  • Results indicated that the NFI-MS-G had strong internal consistency and validity, with good test-retest reliability and readability, successfully distinguishing between different patient groups and constructing a two-domain subtest to better evaluate fatigue.
View Article and Find Full Text PDF

Objectives: To determine the psychometric validity, using Rasch analysis, of summing the three constituent parts of the Glasgow Coma Scale (GCS).

Design: National (registry-based) retrospective study.

Setting: England and Wales.

View Article and Find Full Text PDF

Background: The C19-YRS is the literature's first condition-specific, validated scale for patient assessment and monitoring in Post-COVID-19 syndrome (PCS). The 22-item scale's subscales (scores) are symptom severity (0-100), functional disability (0-50), additional symptoms (0-60), and overall health (0-10).

Objectives: This study aimed to test the scale's psychometric properties using Rasch analysis and modify the scale based on analysis findings, emerging information on essential PCS symptoms, and feedback from a working group of patients and professionals.

View Article and Find Full Text PDF

Introduction: Long COVID, a new condition whose origins and natural history are not yet fully established, currently affects 1.5 million people in the UK. Most do not have access to specialist long COVID services.

View Article and Find Full Text PDF

Background: The importance of patient-reported outcome measurement in chronic kidney disease (CKD) populations has been established. However, there remains a lack of research that has synthesised data around CKD-specific symptom and health-related quality of life (HRQOL) burden globally, to inform focused measurement of the most relevant patient-important information in a way that minimises patient burden. The aim of this review was to synthesise symptom prevalence/severity and HRQOL data across the following CKD clinical groups globally: (1) stage 1-5 and not on renal replacement therapy (RRT), (2) receiving dialysis, or (3) in receipt of a kidney transplant.

View Article and Find Full Text PDF

Background: The current standard of care in rheumatoid arthritis (RA) requires regular assessment of disease activity (DA). All standard RA DA measurement instruments require joint counts to be undertaken by a healthcare professional with/without a blood test. Few healthcare providers have the capacity to assess patients as frequently as stipulated by guidelines.

View Article and Find Full Text PDF

Many physical activity (PA) interventions implemented to tackle the child obesity epidemic have shown limited effectiveness, possibly due to a lack of consideration of potential stress that accompanies behavior adaptation and the automatic perseverative cognition that exacerbates the stress (namely rumination). : The main aim of this paper is to develop and validate the PA-specific Rumination Scale for Children (PARSC) that assesses children's tendencies to engage in repeated negative thoughts about PA (Study 2). Items in the scale were derived from qualitative information about factors that inherently demotivates PA participation (intrinsic barriers) through the lived experience of UK children (Study 1).

View Article and Find Full Text PDF

Purpose: To identify and comprehensively evaluate studies capturing the experience of individuals affected by an inherited optic neuropathy (ION), focusing on patient-reported outcome measures (PROMs) and qualitative studies where the health status and quality of life (QoL) of these individuals have been explored.

Methods: Systematic review of five databases using a search strategy combining four concepts: (1) ION; (2) QoL and health status; (3) PROMs; and (4) qualitative research. Studies assessing the impact of ION on any QoL domain using a PROM or qualitative methodology were included and appraised, using criteria based on the COSMIN checklist (for PROM studies) and the CASP checklist (for qualitative studies).

View Article and Find Full Text PDF

As our understanding of the nature and prevalence of post-coronavirus disease 2019 (COVID-19) syndrome (PCS) is increasing, a measure of the impact of COVID-19 could provide valuable insights into patients' perceptions in clinical trials and epidemiological studies as well as routine clinical practice. To evaluate the clinical usefulness and psychometric properties of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) in patients with PCS, a prospective, observational study of 187 consecutive patients attending a post-COVID-19 rehabilitation clinic was conducted. The C19-YRS was used to record patients' symptoms, functioning, and disability.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed data from 600 patients and found that the BCTQ items cannot be summed for an overall score, indicating the need for separate treatment of its two subscales: Symptom Severity Subscale (SSS) and Functional Status Subscale (FSS).
  • * The research suggests creating a new scoring system for the SSS to improve measurement accuracy and recommends addressing issues within the FSS for better psychometric integrity.
View Article and Find Full Text PDF

Objectives: Dementia affects many people, with numbers expected to grow as populations age. Many people with dementia receive informal/family/unpaid care, for example, from a spouse or child, which may affect carer quality of life. Measuring the effectiveness of health/social care interventions for carers requires a value measure of the quality-of-life impact of caring.

View Article and Find Full Text PDF
Article Synopsis
  • A 2008 European consensus found that measuring the quality of life (QoL) of dementia carers was insufficient, leading to the development of reliable tools recommended in 2017.
  • This study aimed to create a new QoL measurement instrument for dementia carers by directly gathering input from 566 carers across 22 locations in England and Wales.
  • The resulting SIDECAR scales, which quantify the direct and indirect impact of caregiving and the need for support, demonstrate strong psychometric properties and are freely available for use in various sectors.
View Article and Find Full Text PDF